[HTML][HTML] Aged population and immunocompromised patients: impact on SARS-CoV-2 variants and treatment outcomes

VP Chavda, MT Chhabria, V Apostolopoulos - Biologics, 2022 - mdpi.com
Patients with an immunocompromised state are at risk of developing a long-term infection
from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). It has …

[PDF][PDF] Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes. Biologics 2022, 2, 165–170

VP Chavda, MT Chhabria, V Apostolopoulos - 2022 - pdfs.semanticscholar.org
Patients with an immunocompromised state are at risk of developing a long-term infection
from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). It has …

[引用][C] Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes

VP Chavda, MT Chhabria, V Apostolopoulos - 2022 - agris.fao.org
Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and
Treatment Outcomes Food and Agriculture Organization of the United Nations Discover About …

Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes

VP Chavda, MT Chhabria, V Apostolopoulos - Biologics, 2022 - search.proquest.com
Abstract According to Mueller AL [7], the viral replication process is favoured in aged and
immunocompromised individuals due to inefficiency of the circulatory macrophages and …

[PDF][PDF] Aged population and immunocompromised patients: impact on SARS-CoV-2 variants and treatment outcomes

VP Chavda, M Chhabria, V Apostolopoulos - Biologics, 2022 - vuir.vu.edu.au
Patients with an immunocompromised state are at risk of developing a long-term infection
from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). It has …

[引用][C] Aged population and immunocompromised patients: impact on SARS-CoV-2 variants and treatment outcomes

VP Chavda, M Chhabria, V Apostolopoulos - Biologics, 2022 - vuir.vu.edu.au